Webinar
Contents
Chair(s)

Giovanni Martinelli
Scientific Director at Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) Srl-IRCCS, Meldola, Italy.

Claudio Cerchione
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) Srl-IRCCS, Meldola, Italy.
Speaker(s)

Claudio Cerchione
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) Srl-IRCCS, Meldola, Italy.
Topic: How I manage Multiple Myeloma - State of the art
Topic: How I manage Multiple Myeloma - State of the art

Carolina Terragna
IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", Italy.
Topic:Molecular biology in myeloma
Topic:Molecular biology in myeloma

Fabio Malavasi
Immunogenetics Laboratory, Department of Medical Sciences, University of Torino, Torino, Italy.
Topic: Anti-CD38 antibody therapy: basic science and combined immunotherapy strategies
Topic: Anti-CD38 antibody therapy: basic science and combined immunotherapy strategies

Giovanni Martinelli
Scientific Director at Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) Srl-IRCCS, Meldola, Italy.
Topic: Importance of network in Multiple Myeloma: where are we going?
Topic: Importance of network in Multiple Myeloma: where are we going?

Alessandro Gozzetti
Hematology, University of Siena, Policlinico Le Scotte, Siena , Italy.
Topic: Daratumumab treatment for multiple myeloma patients in >VGPR but MRD positive by NGF after 1st line therapy
Topic: Daratumumab treatment for multiple myeloma patients in >VGPR but MRD positive by NGF after 1st line therapy

Daniela de Totero
Molecular Pathology Unit, IRCCS Ospedale Policlinico San Martino, Italy.
Topic: The HGF/c-MET axis as a potential target to overcome survival signals and improve therapeutic efficacy in multiple myeloma
Topic: The HGF/c-MET axis as a potential target to overcome survival signals and improve therapeutic efficacy in multiple myeloma
Programme
Programme
- Time (GMT+2)
- Speakers
- Topic
- 5:00-5:05 PM
- Giovanni Martinelli & Claudio Cerchione
- Welcoming Speech
- 5:05-5:15 PM
- Giovanni Martinelli
- Importance of network in Multiple Myeloma: where are we going?
- 5:15-5:20 PM
- Claudio Cerchione
- Disscussion with the speaker (Q&A )
- 5:20-5:30 PM
- Carolina Terragna
- Molecular biology in myeloma
- 5:30-5:35 PM
- Giovanni Martinelli & Claudio Cerchione
- Disscussion with the speaker (Q&A )
- 5:35-5:45 PM
- Fabio Malavasi
- Anti-CD38 antibody therapy: basic science and combined immunotherapy strategies
- 5:45-5:50 PM
- Giovanni Martinelli & Claudio Cerchione
- Disscussion with the speaker (Q&A )
- 5:50-6:00 PM
- Alessandro Gozzetti
- Daratumumab treatment for multiple myeloma patients in >VGPR but MRD positive by NGF after 1st line therapy
- 6:00-6:05 PM
- Giovanni Martinelli & Claudio Cerchione
- Disscussion with the speaker (Q&A )
- 6:05-6:15 PM
- Daniela de Totero
- The HGF/c-MET axis as a potential target to overcome survival signals and improve therapeutic efficacy in multiple myeloma
- 6:15-6:20 PM
- Giovanni Martinelli & Claudio Cerchione
- Disscussion with the speaker (Q&A )
- 6:20-6:30 PM
- Claudio Cerchione
- How I manage Multiple Myeloma - State of the art
- 6:20-6:30 PM
- Giovanni Martinelli
- Disscussion with the speaker (Q&A )
- 6:30-6:50 PM
- Giovanni Martinelli & Claudio Cerchione
- Free Disscussion
- 6:50-6:55 PM
- Assistant Editor
- Jounral Introduction
- 6:55-7:00 PM
- Giovanni Martinelli & Claudio Cerchione
- Conclusion Comments
Moments






Presentation

Prof. Alessandro Gozzetti
Topic: DART4MM: Daratumumab as consolidation therapy in MRD positive MM patients
NaN

Prof. Carolina Terragna
Topic:Importance of Minimal Residual Disease assessment within the bone marrow of Multiple Myeloma
NaN

Prof. Claudio Cerchione
Topic: How I manage Multiple Myeloma - State of the art
NaN

Prof. Daniela de Totero
Topic: The involvement of HGF/c-MET interaction in the pathogenesis of Multiple Myeloma and the possibility of targeting this interaction
NaN

Prof. Fabio Malavasi
Topic: CD38 in basic science and clinical practice: reflecting on the past to move to the future
NaN

Prof. Giovanni Martinelli
Topic: Importance of network in Multiple Myeloma: where are we going?
NaN